10.04.2012 • News

Cardinal Hires New Head of Medical Business

Cardinal Health has named a former longtime Johnson & Johnson executive as the new head for its $9 billion medical products and services business, the U.S. pharmaceutical wholesaler said on Tuesday.

Donald Casey replaces Mike Lynch, who Cardinal said was leaving to pursue his ambition to lead a company of his own in the Chicago area. Lynch will stay on at Cardinal on a part-time basis through September.

The medical segment for which Casey assumes responsibility includes medical and surgical products and services for hospitals, physician offices and other healthcare providers, and represents about 9% of Cardinal's $103 billion in overall annual revenue.

Casey joins Cardinal from the Gary and Mary West Wireless Health Institute, a nonprofit research organization where he served as the organization's first chief executive.

Prior to West Health, Casey spent 24 years at J&J, most recently as a member of the company's executive committee and chairman of the business that included cardiovascular, diagnostic, diabetes and vision products.

Casey will report to Cardinal CEO George Barrett.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.